Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

Blood (2017) 130 (3): 360–367.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals